In the version of this article initially published, in Table 8, Enbrel (etanercept) was left off the table. It should have been in the number 2 spot in the table with 2013 revenue at $8,729 million. In addition, the units of the last column, which are in $ millions, were omitted in the title. The error has been corrected in the HTML and PDF versions of the article.
Additional information
The online version of the original article can be found at 10.1038/nbt.2949
Rights and permissions
About this article
Cite this article
Lawrence, S., Lahteenmaki, R. Erratum: Public biotech 2013—the numbers. Nat Biotechnol 32, 1166 (2014). https://doi.org/10.1038/nbt1114-1166c
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1114-1166c
